Bionik Laboratories's total inventories for the quarter that ended in Mar. 2023 was $1.03 Mil. Bionik Laboratories's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Mar. 2023 was $1.09 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Bionik Laboratories's Net-Net Working Capital per share for the quarter that ended in Mar. 2023 was $-0.54.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bionik Laboratories's Days Inventory for the
three
months ended in Mar. 2023 was 402.31.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bionik Laboratories's Inventory Turnover for the quarter that ended in Mar. 2023 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bionik Laboratories's Inventory-to-Revenue for the quarter that ended in Mar. 2023 was 2.17.
Bionik Laboratories (OTCPK:BNKL) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Bionik Laboratories's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2023 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bionik Laboratories's Inventory to Revenue for the quarter that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Bionik Laboratories Total Inventories Related Terms
Bionik Laboratories Total Inventories Historical Data
* Premium members only.
The historical data trend for Bionik Laboratories's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Bionik Laboratories (BNKL) has a Total Inventories of $1.03 Mil as of Mar. 2023. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bionik Laboratories and its competitors.
Is Bionik Laboratories' Total Inventories too high?
Bionik Laboratories' current Total Inventories is $1.03 Mil. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' Total Inventories compare to ARPC and GRST?
Bionik Laboratories' Total Inventories of $1.03 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bionik Laboratories and its competitors. Bionik Laboratories's current Total Inventories is $1.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current Total Inventories of $1.03 Mil. The current Total Inventories is $1.03 Mil. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current Total Inventories is $1.03 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score
Get the complete analysis for BNKL
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BNKL has been successfully added to your 
